Article
Resistant mutations and quasispecies complexity of hepatitis B virus during telbivudine treatment.
The Journal of general virology - 1 Nov 2015
Yin Feifei, Wu Zeguang, Fang Wei, Wu Chunchen, Rayner Simon, Han Meifang, Deng Fei, Du Ruikun, Liu Jinliang, Wang Manli, Wang Hualin, Ning Qin, Hu Zhihong
Abstract excerpt
Ultra-deep pyrosequencing (UDPS) was used to analyse the dynamics of quasispecies and resistant mutations during telbivudine (LDT) treatment of hepatitis B patients. Twenty-six HBeAg-positive chronic hepatitis B patients were treated with LDT for a period of 104 weeks and were characterized as 16 responders, six partial responders and four viral breakthrough patients based on hepatitis B virus (HBV) DNA levels....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
